Newsroom Stories

Researchers from the School of Medicine have found that the immune system may be triggered to treat atherosclerosis and possibly other metabolic conditions, including fatty liver disease and type 2 diabetes.

The National Institutes of Health awarded a biomedical engineer at Washington University in St. Louis a 4-year, $1.7 million grant to attempt to develop a new way to image airflow in lungs. The research could someday make diagnoses of lung disease easier and more cost-effective.

Washington University in St. Louis is one of 24 schools selected to receive $1 million grants as part of a new HHMI initiative to help colleges and universities foster success in science for all students, especially undergraduates who enter four-year institutions via nontraditional pathways.

President Donald Trump has made the decision to pull the U.S. out of the 2015 Paris climate agreement, a move that that cannot be justified on the stated grounds for withdrawal, says an expert in environmental law at Washington University in St. Louis.

On behalf of Washington University, Chancellor Mark S. Wrighton issued a statement regarding President Trump’s decision to withdraw the United States from the Paris Climate Change Accord.

A new study by anesthesiologists at Washington University School of Medicine in St. Louis and the University of Michigan Medical School sheds new light on the drug ketamine.

A team of biomedical engineers at Washington University in St. Louis recently completed a study offering profound implications for how sensory information may be encoded in the brain.

Philanthropists Anne and John McDonnell became the 18th couple awarded the annual Jane and Whitney Harris St. Louis Community Service Award, which honors a St. Louis husband-and-wife team who contributed in an outstanding manner to the civic and cultural well-being of the region.

Tiffany M. Osborn, MD, professor of surgery and of emergency medicine at Washington University School of Medicine in St. Louis is a leading expert in sepsis. She co-authored a study published May 21 in The New England Journal of Medicine that stresses the need for an aggressive response to the condition.

Using genomics, a chemistry lab has worked out the biosynthetic machinery that makes a new class of antibiotic compounds called the beta-lactones. Like the beta-lactams, such as penicillin, they have an unstable four-member ring. The key to their antibiotic activity, it is also difficult to synthesize.